United Therapeutics Corporation Effective Income Tax Rate Reconciliation, Tax Credit, Amount
United Therapeutics Corporation (UTHR) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $28.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2025-02-26
- United Therapeutics Corporation effective income tax rate reconciliation, tax credit, amount for fiscal 2024 was $28.00M, a 24.44% increase from fiscal 2023.
- United Therapeutics Corporation effective income tax rate reconciliation, tax credit, amount for fiscal 2023 was $22.50M, a 25.00% increase from fiscal 2022.
- United Therapeutics Corporation effective income tax rate reconciliation, tax credit, amount for fiscal 2022 was $18.00M, a 56.52% increase from fiscal 2021.
- United Therapeutics Corporation effective income tax rate reconciliation, tax credit, amount for fiscal 2021 was $11.50M, a 52.08% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | $28.00M 10-K · filed 2025-02-26 | |
| 2023-12-31 | $22.50M 10-K · filed 2025-02-26 | |
| 2022-12-31 | $18.00M 10-K · filed 2025-02-26 | |
| 2021-12-31 | $11.50M 10-K · filed 2024-02-21 | |
| 2020-12-31 | $24.00M 10-K · filed 2023-02-22 | |
| 2019-12-31 | $21.30M 10-K · filed 2022-02-24 | $20.40M 10-K · filed 2020-02-26 |
| 2018-12-31 | $16.00M 10-K · filed 2021-02-24 | $14.90M 10-K · filed 2019-02-27 |
| 2017-12-31 | $15.10M 10-K · filed 2020-02-26 | |
| 2016-12-31 | $10.50M 10-K · filed 2019-02-27 | |
| 2015-12-31 | $6.90M 10-K · filed 2018-02-21 | $6.90M 10-K · filed 2016-02-25 |
| 2014-12-31 | $12.20M 10-K · filed 2017-02-22 | $12.20M 10-K · filed 2015-02-24 |
| 2013-12-31 | $13.35M 10-K · filed 2016-02-25 | |
| 2012-12-31 | $10.98M 10-K · filed 2015-02-24 | |
| 2011-12-31 | $15.78M 10-K · filed 2014-02-25 | |
| 2010-12-31 | $14.76M 10-K · filed 2013-02-26 | |
| 2009-12-31 | $10.90M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |